v3.26.1
Stockholders' Equity
12 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Stockholders' Equity

17. STOCKHOLDERS’ EQUITY

Dividends

Dividends are recorded if and when they are declared by the board of directors.

On July 3, 2025, the Company's board of directors declared a regular cash dividend of $0.20 per share of common stock to stockholders of record at the close of business on July 18, 2025. The dividend was paid on August 1, 2025 and totaled $4.9 million.

On October 28, 2025, the Company's board of directors declared a regular dividend of $0.20 per share of common stock to stockholders of record at the close of business on November 19, 2025. The dividend was paid on December 2, 2025 and totaled $4.9 million.

On February 2, 2026, the Company's board of directors declared a regular dividend of $0.20 per share of common stock to stockholders of record at the close of business on February 20, 2026. The dividend was paid on March 4, 2026 and totaled $5.7 million.

On May 5, 2026, the Company's board of directors declared a regular dividend of $0.20 per share of common stock to stockholders of record at the close of business on May 20, 2026. The dividend was paid on June 1, 2026 and totaled $5.8 million.

Share Repurchase Program

The Company has an ongoing share repurchase program authorizing the purchase of up to 3.3 million shares of common stock. As of June 30, 2026, 2.0 million shares remained authorized for repurchase under the program. During the year ended June 30, 2026, we did not repurchase any shares under our share repurchase program. From inception of the program through June 30, 2026, we repurchased a total of 1,321,003 shares for $37.3 million, of which 139,455 shares were repurchased from a related party (see Note 14 for further information). We are not obligated to repurchase any shares under the program, and repurchases under the program may be discontinued if management determines that additional repurchases are not warranted.

Tether Investment

In February 2026, the Company entered into a definitive agreement with Tether, whereby Tether purchased $126.4 million of the Company’s common stock. In May 2026, following the receipt of clearance under the Hart-Scott-Rodino Act, Tether purchased an additional $23.6 million of the Company’s common stock. The purchase price for the common stock was $44.50 per share. The shares purchased by Tether were subject to a 90-day resale restriction which ended May 7, 2026. The Company also entered into an investor rights agreement, under which Tether was entitled to nominate a member to the Company’s board of directors and received certain registration rights. During the year ended June 30, 2026, the Company incurred transaction costs of $10.0 million related to the sale of common stock to Tether, resulting in net proceeds of $140.0 million.

2014 Stock Award and Incentive Plan

The Company's amended and restated 2014 Stock Award and Incentive Plan (the "2014 Plan") was approved most recently on October 27, 2022 by the Company's stockholders. As of June 30, 2026, 1,350,928 shares were available for issuance of new awards under the 2014 Plan. Under the 2014 Plan, the Company may grant stock options, restricted stock, restricted stock units ("RSUs"), stock appreciation rights ("SARs"), and other equity-based or cash incentive awards to employees, directors, and consultants. The plan permits performance-based and market-based conditions on awards. The maximum contractual term of options and SARs is ten years. Shares delivered under the 2014 Plan are either newly issued shares or treasury shares. Authority to grant new awards under the plan expires on October 27, 2032.

Stock Options

The Company measures the compensation cost of stock options using the Black-Scholes option pricing model, which uses various inputs such as the market price per share of common stock and estimates that include the risk-free interest rate, volatility, expected life and dividend yield. The weighted-averages for key assumptions used in determining the fair value of options granted were as follows:

 

 

Year Ended June 30,

 

 

2026

 

2025

 

 

2024

Average volatility

 

50.83%

 

50.07%

 

 

n/a (1)

Risk-free interest rate

 

3.90%

 

4.01%

 

 

n/a (1)

Weighted-average expected life in years

 

6.5

 

6.6

 

 

n/a (1)

Dividend yield rate annual

 

3.69%

 

3.15%

 

 

n/a (1)

 

(1)
Not applicable; no employee stock options were issued.

The expected volatility was based on a combination of the historical volatility of the Company’s common stock over a period commensurate with the expected term and the implied volatility derived from the market prices of the traded options. The risk-free interest rate was derived from the average U.S. Treasury yields with a term matching the expected life of the option. To date, the Company has used the simplified method to estimate the expected term as sufficient historical exercise data has not been available. The simplified method calculates the expected term as the midpoint between the vesting and contractual terms. The dividend yield was based on the historical and expected dividend payouts as of the respective award grant dates.

The Company incurred compensation expense related to stock options of $1.1 million, $0.4 million and $0.7 million during the years ended June 30, 2026, 2025, and 2024, respectively. As of June 30, 2026, there was total remaining compensation expense of $1.1 million related to employee stock options, which will be recorded over a weighted-average vesting period of approximately 2.0 years. The Company recognizes forfeitures as they occur.

The following table summarizes stock option activity:

 

 

Options

 

 

Weighted-Average Exercise Price Per Share

 

 

Aggregate
Intrinsic Value
(in thousands)

 

 

Weighted-Average Grant Date Fair Value Per Award (1)

 

Fiscal 2024

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2023

 

 

1,446,260

 

 

$

7.11

 

 

$

43,882

 

 

$

3.58

 

Exercises

 

 

(287,730

)

 

$

7.17

 

 

$

7,720

 

 

$

3.82

 

Outstanding at June 30, 2024

 

 

1,158,530

 

 

$

7.10

 

 

$

29,354

 

 

$

3.53

 

Nonvested outstanding June 30, 2024

 

 

41,664

 

 

$

20.49

 

 

$

532

 

 

$

9.23

 

Exercisable at June 30, 2024

 

 

1,116,866

 

 

$

6.60

 

 

$

28,822

 

 

$

3.32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2025

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

1,158,530

 

 

$

7.10

 

 

$

29,354

 

 

$

3.53

 

Grants

 

 

255,000

 

 

$

25.43

 

 

$

 

 

$

10.22

 

Exercises

 

 

(235,668

)

 

$

14.03

 

 

$

6,909

 

 

$

6.47

 

Outstanding at June 30, 2025

 

 

1,177,862

 

 

$

9.68

 

 

$

15,728

 

 

$

4.39

 

Nonvested outstanding June 30, 2025

 

 

243,333

 

 

$

25.35

 

 

$

 

 

$

10.17

 

Exercisable at June 30, 2025

 

 

934,529

 

 

$

5.60

 

 

$

15,728

 

 

$

2.88

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2026

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2025

 

 

1,177,862

 

 

$

9.68

 

 

$

15,728

 

 

$

4.39

 

Grants

 

 

73,000

 

 

$

30.86

 

 

$

631

 

 

$

12.59

 

Exercises

 

 

(463,035

)

 

$

8.25

 

 

$

15,092

 

 

$

3.64

 

Forfeitures

 

 

(100,000

)

 

$

25.24

 

 

$

 

 

$

10.09

 

Outstanding at June 30, 2026

 

 

687,827

 

 

$

10.63

 

 

$

21,322

 

 

$

5.14

 

Nonvested outstanding June 30, 2026

 

 

116,333

 

 

$

25.09

 

 

$

1,935

 

 

$

10.10

 

Exercisable at June 30, 2026

 

 

571,494

 

 

$

7.69

 

 

$

19,387

 

 

$

4.13

 

 

(1)
The Company issued the options with an exercise price per share not less than the closing market price of common stock on the grant date.

 

The following table presents information related to outstanding options as of June 30, 2026:

Exercise Price Ranges

 

 

Options Outstanding

 

 

Options Exercisable

 

From

 

 

To

 

 

Number of
 Underlying
 Shares

 

 

Weighted-Average Remaining Contractual Life
(Years)

 

 

Weighted-Average Exercise Price

 

 

Number of
 Underlying
 Shares

 

 

Weighted-Average Remaining Contractual Life
(Years)

 

 

Weighted-Average Exercise Price

 

$

 

 

$

2.50

 

 

 

337,294

 

 

 

3.41

 

 

$

1.60

 

 

 

337,294

 

 

 

3.41

 

 

$

1.60

 

$

2.51

 

 

$

5.00

 

 

 

99,200

 

 

 

2.15

 

 

$

3.51

 

 

 

99,200

 

 

 

2.15

 

 

$

3.51

 

$

5.01

 

 

$

20.00

 

 

 

30,000

 

 

 

3.90

 

 

$

12.99

 

 

 

30,000

 

 

 

3.90

 

 

$

12.99

 

$

20.01

 

 

$

30.00

 

 

 

178,333

 

 

 

8.80

 

 

$

24.66

 

 

 

65,000

 

 

 

8.79

 

 

$

24.88

 

$

30.01

 

 

$

60.00

 

 

 

43,000

 

 

 

7.20

 

 

$

38.03

 

 

 

40,000

 

 

 

7.01

 

 

$

37.44

 

 

 

 

 

 

 

687,827

 

 

 

4.88

 

 

$

10.63

 

 

 

571,494

 

 

 

4.08

 

 

$

7.69

 

Restricted Stock Units

RSUs granted by the Company are not transferable and automatically convert to shares of common stock on a one-for-one basis as the awards vest or at a specified date after vesting. RSUs granted to a non-U.S. citizen are referred to as "deferred stock units" or "DSUs". The Company measures the compensation cost of RSUs based on the closing price of the underlying shares at the grant date. The Company recognizes forfeitures as they occur.

The Company incurred compensation expense related to RSUs of $1.3 million, $1.2 million, and $1.2 million during the years ended June 30, 2026, 2025, and 2024, respectively. As of June 30, 2026, there was $2.1 million of remaining compensation expense related to RSUs, which will be recorded over a weighted-average vesting period of approximately 2.3 years. The following table summarizes RSU activity:

 

 

Awards
Outstanding

 

 

 

Weighted-Average Fair Value per Unit at Grant Date

 

 

Fiscal 2024

 

 

 

 

 

 

 

 

Nonvested outstanding at June 30, 2023

 

 

63,587

 

 

 

$

32.37

 

 

Granted

 

 

38,135

 

 

 

$

28.18

 

 

Vested & delivered

 

 

(24,696

)

 

 

$

31.69

 

 

Vested & deferred (1)

 

 

(12,577

)

 

 

$

29.69

 

 

Forfeited

 

 

(3,132

)

 

 

$

36.19

 

 

Nonvested outstanding at June 30, 2024

 

 

61,317

 

 

 

$

30.61

 

 

Vested but subject to deferred settlement at June 30, 2024 (1)

 

 

41,947

 

 

 

$

26.06

 

 

Outstanding at June 30, 2024

 

 

103,264

 

 

 

$

28.76

 

 

Fiscal 2025

 

 

 

 

 

 

 

 

Nonvested outstanding at June 30, 2024

 

 

61,317

 

 

 

$

30.61

 

 

Granted

 

 

60,235

 

 

 

$

24.31

 

 

Vested & delivered

 

 

(23,093

)

 

 

$

23.64

 

 

Vested & deferred (1)

 

 

(14,203

)

 

 

$

28.90

 

 

Forfeited

 

 

(1,566

)

 

 

$

36.19

 

 

Nonvested outstanding at June 30, 2025

 

 

82,690

 

 

 

$

26.59

 

 

Vested but subject to deferred settlement at June 30, 2025 (1)

 

 

56,150

 

 

 

$

26.78

 

 

Outstanding at June 30, 2025

 

 

138,840

 

 

 

$

26.67

 

 

Fiscal 2026

 

 

 

 

 

 

 

 

Nonvested outstanding at June 30, 2025

 

 

82,690

 

 

 

$

26.59

 

 

Granted

 

 

57,060

 

 

 

$

33.35

 

 

Vested & delivered

 

 

(27,041

)

 

 

$

26.51

 

 

Vested & deferred (1)

 

 

(16,243

)

 

 

$

27.70

 

 

Forfeited

 

 

(1,566

)

 

 

$

36.19

 

 

Nonvested outstanding at June 30, 2026

 

 

94,900

 

 

 

$

30.07

 

 

Vested but subject to deferred settlement at June 30, 2026 (1)

 

 

57,742

 

 

 

$

26.96

 

 

Outstanding at June 30, 2026

 

 

152,642

 

 

 

$

28.89

 

 

 

(1)
Certain RSU holders elected to defer settlement of the RSUs to a specified date.

 

Cash Incentive Bonus Award

Effective in the first quarter of fiscal 2024, the Company granted its chief executive officer a cash incentive bonus payable at the end of the fiscal 2024–2027 term, based on two percent of total stockholder return, net of salary and annual bonuses. The award is valued using a Black-Scholes model. The grant date fair value of this liability award was $5.7 million. The fair value of this liability award was $3.4 million as of June 30, 2026 resulting from the following assumptions: a performance bonus estimate of $2.2 million to be paid over the four-year term, a risk-free rate of 4.0%, and an equity volatility of 55.0%.

Compensation expense is recognized on a straight-line basis over the performance period, with the amount recognized fluctuating due to remeasurement of fair value at the end of each reporting period. The Company recognized compensation expense (income) related to this cash incentive bonus award of $2.1 million, ($0.3 million), and $0.8 million during the years ended June 30, 2026, 2025, and 2024, respectively.